We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3-in-1 System with Steerable Balloon and RF Puncture Enables Successful Left Atrial Procedures

By HospiMedica International staff writers
Posted on 04 Apr 2022

A novel all-in-one radiofrequency (RF) puncture and steerable balloon introducer system for transseptal punctures aims to provide a predictable and safe solution for electrophysiology and structural heart interventions requiring left atrial access. More...

The SafeCross Transseptal RF Puncture & Steerable Balloon Introducer System from East End Medical (Miramar, FL, USA), which includes a bi-directional steerable introducer sheath with an ultra-visible positioning balloon and RF puncture dilator, is a novel all-in-one system that provides predictable left atrium access to support transseptal interventions. Uniquely designed with an atraumatic contrast-filled positioning balloon on its distal end, the introducer sheath is ultra-visible under echocardiography and X-ray to facilitate precise puncture site selection, while its bi-directional steerability allows for safe maneuvering and perpendicular placement on the septum.

The proprietary RF puncture dilator delivers electrical energy quickly and predictably to puncture the atrial septum. Designed to be compatible with commonly available electrosurgical generators, the needle-less SafeCross System can be easily adopted into clinical practice. The SafeCross Transseptal RF Puncture & Steerable Balloon Introducer System has received U.S. Food and Drug Administration (FDA) clearance and the first commercial devices have been implanted during Left Atrial Appendage Closure (LAAC) and Transcatheter Mitral Valve Edge-to-Edge Repair (TEER) procedures at US hospitals.

"Accessing the left atrium in a safe and precise manner is critical for optimal patient outcomes in left atrial procedures. Depending on the anatomy, achieving safe and precise transseptal access frequently leads to decreased overall left atrial procedure times," stated Dr. Torsten Vahl, Attending Physician at the Structural Heart & Valve Center, who performed the procedure at New York Presbyterian Hospital. "In using SafeCross, I particularly liked how the balloon-tipped sheath allowed me to safely glide across the septum in small and precise adjustments to enable me to position on the exact pre-determined location of the transseptal puncture."

"The highly visible steerable balloon introducer enables precise puncture site targeting and provides the support needed for challenging anatomies," stated Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services, who performed the procedure at The Mount Sinai Hospital. "Additionally, the ability to use it as a steerable guiding sheath makes it a nice potentially all-in-one tool for my workflow. I look forward to incorporating SafeCross into my left-atrial procedures."

"As a structural heart interventional echocardiographer who helps guide these procedures, the steerable balloon sheath and needle-less RF system provides for a very visible, precise, and safe transseptal experience," said Dr. Rebecca Hahn, Director of Interventional Echocardiography at the Columbia Structural Heart & Valve Center, who joined Dr. Vahl in performing the procedure. "The precision and efficiency with which the interventionalist can now perform the transseptal puncture is remarkable and will likely shorten procedure times and improve procedural success."

"With the increasing number of left atrial procedures, it is imperative to have a left atrial access device that helps physicians safely and predictably cross the septum," commented Dr. Martin Leon, Professor of Medicine at Columbia University Medical Center, who also joined Dr. Vahl in performing the procedure. "The SafeCross system represents a novel tool for successful left atrial procedures including left atrial appendage closure (LAAC), transcatheter mitral valve repair (TEER), and atrial fibrillation (AF) ablation procedures among others. I look forward to collecting clinical evidence on the performance of the SafeCross system and to focusing on training initiatives to improve the safety and efficacy of left atrial procedures."

Related Links:
East End Medical


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.